Historical Valuation
iHuman Inc (IH) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.57 is considered Undervalued compared with the five-year average of -4.01. The fair price of iHuman Inc (IH) is between 4.89 to 5.46 according to relative valuation methord. Compared to the current price of 1.95 USD , iHuman Inc is Undervalued By 60.1%.
Relative Value
Fair Zone
4.89-5.46
Current Price：1.95
60.1%
Undervalued
P/E
EV/EBITDA
EV/EBIT
P/S
P/OCF
P/FCF
1Y
3Y
5Y
Trailing
Forward
iHuman Inc (IH) has a current Price-to-Book (P/B) ratio of 0.73. Compared to its 3-year average P/B ratio of 1.02 , the current P/B ratio is approximately -28.56% higher. Relative to its 5-year average P/B ratio of 1.91, the current P/B ratio is about -61.89% higher. iHuman Inc (IH) has a Forward Free Cash Flow (FCF) yield of approximately 0.00%. Compared to its 3-year average FCF yield of 3.06%, the current FCF yield is approximately -100.00% lower. Relative to its 5-year average FCF yield of 2.09% , the current FCF yield is about -100.00% lower.
P/B
Median3y
1.02
Median5y
1.91
FCF Yield
Median3y
3.06
Median5y
2.09
Competitors Valuation Multiple
AI Analysis for IH
The average P/S ratio for IH competitors is 4.08, providing a benchmark for relative valuation. iHuman Inc Corp (IH.N) exhibits a P/S ratio of 0.57, which is -85.91% above the industry average. Given its robust revenue growth of -14.05%, this premium appears unsustainable.
Performance Decomposition
AI Analysis for IH
1Y
3Y
5Y
Market capitalization of IH increased by 0.00% over the past 1 year. The primary factor behind the change was an decrease in Unknown from 0.00 to 0.00.
The secondary factor is the Unknown, contributed 0.00%to the performance.
Overall, the performance of IH in the past 1 year is driven by Unknown.
People Also Watch
Frequently Asked Questions
Is IH currently overvalued or undervalued?
iHuman Inc (IH) is now in the Undervalued zone, suggesting that its current forward PS ratio of 0.57 is considered Undervalued compared with the five-year average of -4.01. The fair price of iHuman Inc (IH) is between 4.89 to 5.46 according to relative valuation methord. Compared to the current price of 1.95 USD , iHuman Inc is Undervalued By 60.10% .
What is iHuman Inc (IH) fair value?
IH's fair value is calculated using relative valuation, based on historical P/E and P/S ranges and their premiums/discounts relative to a competitor average , adjusted by weights. The fair price of iHuman Inc (IH) is between 4.89 to 5.46 according to relative valuation methord.
How does IH's valuation metrics compare to the industry average?
The average P/S ratio for IH's competitors is 4.08, providing a benchmark for relative valuation. iHuman Inc Corp (IH) exhibits a P/S ratio of 0.57, which is -85.91% above the industry average. Given its robust revenue growth of -14.05%, this premium appears unsustainable.
What is the current P/B ratio for iHuman Inc (IH) as of Jan 10 2026?
As of Jan 10 2026, iHuman Inc (IH) has a P/B ratio of 0.73. This indicates that the market values IH at 0.73 times its book value.
What is the current FCF Yield for iHuman Inc (IH) as of Jan 10 2026?
As of Jan 10 2026, iHuman Inc (IH) has a FCF Yield of 0.00%. This means that for every dollar of iHuman Inc’s market capitalization, the company generates 0.00 cents in free cash flow.
What is the current Forward P/E ratio for iHuman Inc (IH) as of Jan 10 2026?
As of Jan 10 2026, iHuman Inc (IH) has a Forward P/E ratio of 7.00. This means the market is willing to pay $7.00 for every dollar of iHuman Inc’s expected earnings over the next 12 months.
What is the current Forward P/S ratio for iHuman Inc (IH) as of Jan 10 2026?
As of Jan 10 2026, iHuman Inc (IH) has a Forward P/S ratio of 0.57. This means the market is valuing IH at $0.57 for every dollar of expected revenue over the next 12 months.